Gene · 3549
NIH grants2,031
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 2,031
Download this page as JSON| Grant | Title | IHH papers | Newest fiscal year |
|---|---|---|---|
| R01AG044034 | Oxidative Stress and the Development of Osteoarthritis | 1 | 2025 |
| R01AR046786 | Stromal Regulation of Basal Cell Carcinoma Formation | 1 | 2025 |
| R01AR048139 | Role and Mechanism of Action of Ksr2, an Obesity and Type 2 Diabetes Gene, in Bone Metabolism | 1 | 2025 |
| R01AR053237 | Lrp5 and Lrp6 signaling in bone mechanotransduction and metabolism | 1 | 2025 |
| R01AR072009 | Investigations of the molecular genetics and pathogenesis of scoliosis. | 1 | 2025 |
| R01AR076973 | Development of enthesopathy in the mouse model of X-linked hypophosphatemia | 1 | 2025 |
| R01AR077761 | Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair | 1 | 2025 |
| R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 1 | 2025 |
| R01AR079150 | Tissue Size and Precision Control in Growing Hair Follicles | 1 | 2025 |
| R01AR079470 | Leveraging immune-fibroblast interactions for biomaterial induced skin regeneration | 1 | 2025 |
| R01AR080416 | ENPP1 regulation of mammalian bone mass | 1 | 2025 |
| R01CA080728 | Oncogenic Impact of eIF4E-dependent RNA Export in Cancer | 1 | 2025 |
| R01CA089713 | Mouse Models of Human Cancer Database | 1 | 2025 |
| R01CA098571 | Molecular Mechanisms of eIF4E Mediated Transformation | 1 | 2025 |
| R01CA149456 | Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancer | 1 | 2025 |
| R01CA159859 | Dysregulation of the Core Binding Factor Complex Inhibits Differentiation and Drives Group 4 Medulloblastoma | 1 | 2025 |
| R01CA193837 | Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | 1 | 2025 |
| R01CA229699 | Targeting aberrant enhancer landscapes in pancreatic cancer | 1 | 2025 |
| R01CA251221 | Mechanisms of Hedgehog signaling in glioblastoma | 1 | 2025 |
| R01CA255369 | CCL2 and CCR2 as metastatic drivers and therapeutic targets in medulloblastoma | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3549/grants?page=9